4.14  0.68 (19.65%)		02-06 16:00
Open: 3.58 High: 4.5356 Volume: 944,852		Pre. Close: 3.46 Low: 3.5 Market Cap: 24(M)

Short term
Mid term
Targets	6-month :	5.29	1-year :	6.18
Resists	First :	4.53	Second :	5.29
Pivot price	3.47
Supports	First :	3.46	Second :	2.79
MAs	MA(5) :	3.88	MA(20) :	3.45
	MA(100) :	5.68	MA(250) :	5.02
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	58.2	D(3) :	63.8
RSI	RSI(14): 57.1
52-week	High :	17.18	Low :	0.85

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ HYPD ] has closed below upper band by 12.9%. Bollinger Bands are 46.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 56 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	4.54 - 4.57	4.57 - 4.59
Low:	3.45 - 3.47	3.47 - 3.5
Close:	4.09 - 4.14	4.14 - 4.18

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Wed, 04 Feb 2026
Hyperion DeFi launches institutional yield vault on Hyperliquid By Investing.com - Investing.com Nigeria

Wed, 04 Feb 2026
Hyperliquid treasury seeks revenue boost using HYPE holdings as options collateral - The Block

Wed, 04 Feb 2026
New Hyperion DeFi vault chases extra yield from on-chain options - stocktitan.net

Wed, 04 Feb 2026
Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol - The Globe and Mail

Tue, 13 Jan 2026
Hyperion DeFi (HYPD) Price Target Increased by 46.87% to 5.99 - Nasdaq

Mon, 05 Jan 2026
DeFi firm Hyperion taps new CEO and top lawyer for 2026 digital asset plans - stocktitan.net

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	-65 (M)
Shares Float	0 (M)
Held by Insiders	8.17e+006 (%)
Held by Institutions	6.43e+006 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	1.063e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-18.47
Profit Margin	0 %
Operating Margin	3 %
Return on Assets (ttm)	543 %
Return on Equity (ttm)	-10.6 %
Qtrly Rev. Growth	345320 %
Gross Profit (p.s.)	183.55
Sales Per Share	122890
EBITDA (p.s.)	-982206
Qtrly Earnings Growth	-7.76e+006 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	-0.23
Price to Sales	0
Price to Cash Flow	0

Dividend	1.81e+006
Forward Dividend	1.94e+006
Dividend Yield	43719800%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.